Published in Antimicrob Agents Chemother on December 01, 1978
Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases. Antimicrob Agents Chemother (1979) 4.93
Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains. Antimicrob Agents Chemother (2008) 1.67
Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams. ACS Chem Biol (2012) 1.29
Clinical and pharmacokinetic evaluation of parental cefoxitin in infants and children. Antimicrob Agents Chemother (1980) 0.79
Penetration of cefoxitin into cerebrospinal fluid of infants and children with bacterial meningitis. Antimicrob Agents Chemother (1982) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. Antimicrob Agents Chemother (1974) 9.66
Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86
Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation. Antimicrob Agents Chemother (1974) 8.84
Micromethod system for identification of anaerobic bacteria. Appl Microbiol (1973) 4.18
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Anaerobic infections (second of three parts). N Engl J Med (1974) 3.18
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Simplified assay for gentamicin in the presence of other antibiotics. Antimicrob Agents Chemother (1973) 2.26
Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother (1974) 1.76
Treatment of aspiration pneumonia and primary lung abscess. Penicillin G vs clindamycin. JAMA (1975) 1.17
On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med (1975) 4.11
Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Antimicrob Agents Chemother (1994) 3.26
Prevalence of alcoholism in general municipal hospital population. N Y State J Med (1971) 2.79
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis. Am J Med (1981) 2.68
Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967. Am J Med (1971) 2.66
Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults. Am J Med (1981) 2.36
Septicemia with non-typhoid salmonella. Medicine (Baltimore) (1974) 2.31
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother (1991) 2.26
Immunologic distinction between infectious and serum hepatitis. N Engl J Med (1970) 2.16
Bone and joint infections due to Salmonella. J Infect Dis (1978) 2.14
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1980) 2.12
Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates. J Infect Dis (1975) 2.09
The medical sequelae of narcotic addiction. Ann Intern Med (1967) 1.68
Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations. Lancet (1972) 1.67
Infectious disease problems of narcotic addicts. Arch Intern Med (1971) 1.62
Symptoms, septicemia and death in salmonellosis. Am J Epidemiol (1969) 1.55
Infective endocarditis in narcotic addicts. Ann Intern Med (1968) 1.52
Risk of post-transfusion hepatitis in recepients of blood containing S.H. antigen at Harlem Hospital. Lancet (1971) 1.45
Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility. Antimicrob Agents Chemother (1982) 1.45
Failure of pneumococcal vaccine in children with sickle-cell disease. N Engl J Med (1979) 1.43
Antibiotic resistance of Salmonella in Europe and the United States. Rev Infect Dis (1982) 1.42
In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents. Antimicrob Agents Chemother (1981) 1.38
Serum hepatitis specific antigen (SH) in commercial and volunteer sources of blood. Transfusion (1971) 1.29
Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens. JAMA (1980) 1.25
Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population. J Assoc Physicians India (2002) 1.22
Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center. Rev Infect Dis (1991) 1.22
Designing appropriate therapy in the treatment of gram-negative bacillary meningitis. JAMA (1982) 1.21
Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus. J Antimicrob Chemother (1985) 1.20
Quinolones for the treatment of infections due to Salmonella. Rev Infect Dis (1991) 1.17
Conditions affecting the results of susceptibility testing for the quinolone compounds. Chemotherapy (1988) 1.16
The serum hepatitis related antigen (SH) in illicit drug users. Am J Epidemiol (1970) 1.13
Treatment of gram-negative bacillary meningitis: role of the new cephalosporin antibiotics. Rev Infect Dis (1983) 1.12
Chronic liver disease in asymptomatic narcotic addicts. Ann Intern Med (1972) 1.10
Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations. Antimicrob Agents Chemother (1991) 1.10
Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin. Antimicrob Agents Chemother (1981) 1.09
Serologic investigations in narcotic addicts. I. Syphilis, lymphogranuloma venereum, herpes simplex, and Q fever. Ann Intern Med (1968) 1.08
Febrile agglutinins in narcotic addicts. Am J Clin Pathol (1970) 1.05
Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens. Antimicrob Agents Chemother (1983) 1.04
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. J Antimicrob Chemother (1993) 1.02
Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp. J Antimicrob Chemother (1987) 1.00
Experience with the use of cefotaxime in the treatment of bacterial meningitis. Am J Med (1986) 0.97
Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Arch Intern Med (1986) 0.97
Penetration of cefoxitin into cerebrospinal fluid and treatment of meningitis caused by gram-negative bacteria. Rev Infect Dis (1989) 0.96
Evaluation of two methods for overcoming the antibiotic carry-over effect. Eur J Clin Microbiol Infect Dis (1991) 0.94
A serologic survey of tetanus and diphtheria immunity in New York City. Arch Environ Health (1967) 0.93
Tetanus despite preexisting antitetanus antibody. JAMA (1978) 0.92
Autoantibodies against GAD65 and IA-2 in recently diagnosed Type 1 diabetic children from Western India. Diabet Med (2004) 0.92
Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis. J Antimicrob Chemother (1984) 0.92
The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus. Diabetes Obes Metab (2011) 0.92
Abnormal neutrophil chemotaxis and random migration induced by aminoglycoside antibiotics. J Lab Clin Med (1979) 0.91
Serologic investigations in narcotic addicts. 3. Latex fixation, C-reactive protein, "Monotest," serum proteins, and SH antigen. Am J Clin Pathol (1971) 0.91
Persistence of transaminase abnormalities in former drug addicts. Ann Intern Med (1972) 0.90
Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci. Antimicrob Agents Chemother (1981) 0.90
Antibody to hepatitis A and B in children in New York City. Pediatrics (1978) 0.89
Antibiotic resistance of salmonella in northeastern United States 1968-199. N Y State J Med (1971) 0.88
The epidemiology of salmonellosis in New York City. Am J Epidemiol (1969) 0.88
A three and half year follow-up study of HBs-Ag carrier state in asymptomatic mothers. Indian J Pathol Microbiol (1982) 0.88
Clindamycin in infective endocarditis. JAMA (1978) 0.87
Epidemiology of tetanus in narcotic addicts. N Y State J Med (1970) 0.86
The natural history of liver disease in former drug users. Am J Med Sci (1977) 0.86
A critique of semiautomated susceptibility systems. Rev Infect Dis (1987) 0.86
Editorial: The emerging epidemiology of hepatitis B antigen. Ann Intern Med (1973) 0.83
Nonspecific reactions to casoni antigen. Am J Trop Med Hyg (1969) 0.83
Serum hepatitis antigen (SH) carrier state: relation to ABO blood groups. Br Med J (1971) 0.83
Antibody to hepatitis A antigen in children. J Pediatr (1977) 0.83
Persistent nocardemia following renal transplantation. Association with pulmonary nocardiosis. JAMA (1978) 0.82
Presumed pneumococcal pneumonia. Treatment with parenteral penicillin, cephaloridine, and lincomycin with continuation on oral therapy. N Y State J Med (1974) 0.82
Medical indices of narcotics addiction. Rise and fall in New York City, 1963-1977. N Y State J Med (1979) 0.82
The genetic basis of hyperhomocysteinemia. Indian Heart J (2001) 0.82
An outbreak of Salmonella enteritis and septicemia in a population of uremic patients. A review of four cases, including infection of an arteriovenous fistula. Arch Intern Med (1980) 0.81
Antibiotic resistance of salmonella. Northeastern United States-1970. N Y State J Med (1972) 0.81
Retroperitoneal abscess caused by Mycobacterium chelonae and treatment. Ann Pharmacother (1993) 0.81
Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents. Rev Infect Dis (1983) 0.81
The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria. J Antimicrob Chemother (1983) 0.80
Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group. Antimicrob Agents Chemother (1991) 0.80
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes. J Antimicrob Chemother (1982) 0.80
Medical treatment of Serratia arthritis with trimethoprim-sulfamethoxazole. Johns Hopkins Med J (1978) 0.79
In-vitro emergence of beta-lactam-resistant variants of Pseudomonas aeruginosa. J Antimicrob Chemother (1986) 0.79
A sudden decline in ampicillin resistance in Salmonella typhimurium. JAMA (1980) 0.79
Salmonellosis in man. Lancet (1973) 0.78
In vitro activity of U-57930E, a new clindamycin analog, against aerobic gram-positive bacteria. Antimicrob Agents Chemother (1982) 0.78
Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria. Chemotherapy (1988) 0.78
Salmonella infection with multiple serotypes. Am J Med Sci (1970) 0.78
Use of cefoxitin sodium in difficult-to-treat infections. J Antimicrob Chemother (1978) 0.78
Utilization of rehabilitation services by rural households with disabled preschool children. Indian Pediatr (2009) 0.77
Comparison of antibiotic resistance of gram-negative bacilli with beta-lactam and aminoglycoside antibiotics. Diagn Microbiol Infect Dis (1986) 0.77
Pleurocerebral Nocardia in a patient with human immunodeficiency virus. Ann Pharmacother (1992) 0.77
Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trial. Am J Med (1987) 0.77
Nocardiosis in patients with AIDS. Clin Infect Dis (1992) 0.77
Nephrotic syndrome in drug addicts. N Y State J Med (1974) 0.77
Cefotaxime in the treatment of meningitis. Infection (1985) 0.77
Clinical severity of tetanus in narcotic addicts in New York City. Arch Intern Med (1968) 0.76
A case of Trichosporon beigelii endocarditis 8 years after aortic valve replacement. Clin Cardiol (1994) 0.76
Susceptibility testing of Listeria monocytogenes. A reassessment of bactericidal activity as a predictor for clinical outcome. Diagn Microbiol Infect Dis (1991) 0.76